TETROFOSMIN in patients with CAD

Aim of the study

Hypothesis is that gSPECT improves the sensitivity, specificity and prognostic value of MPS of patients withknown or suspected CAD.
Assessment of the incremental value of gSPECT in comparison with conventional SPECT 99'Tc perfusion scintigraphy at the subgroup level. Development of criteria to increase both the number of patients with negative test results and the negative predictive value itself. This may result in more cost-effective management strategies.